DDI3 Antibody

Introduction to DDIT3 Antibodies

DDIT3 antibodies are immunological tools designed to detect and quantify the DDIT3 protein, a transcription factor central to cellular stress responses. DDIT3 is induced by endoplasmic reticulum (ER) stress, DNA damage, and nutrient deprivation, playing dual roles in apoptosis and adaptive signaling . Antibodies targeting DDIT3 enable researchers to study its expression, post-translational modifications (e.g., phosphorylation at Ser30), and involvement in pathologies such as cancer and autoimmune disorders .

3.1. Mechanistic Studies of ER Stress

DDIT3 antibodies are critical for investigating the unfolded protein response (UPR). For example:

• Isochaihulactone-induced ER stress upregulates DDIT3 and NAG-1, driving apoptosis in glioblastoma cells .

• Tunicamycin treatment increases DDIT3 expression, detectable via western blot (WB) using ab11419 .

3.2. Cancer Research

• DDIT3 overexpression correlates with chemoresistance in ovarian cancer, as shown by immunohistochemistry (IHC-P) .

• Co-regulation with ATF4: DDIT3 antibodies identify synergies between ER stress and integrated stress response pathways .

3.3. Neurodegenerative Diseases

• Alzheimer’s disease models utilize DDIT3 antibodies to map ER stress in neuronal cells .

Key Research Findings Using DDIT3 Antibodies

1. Phosphorylation Dynamics: Phospho-Ser30 DDIT3 (detected by ab63392) is elevated during prolonged ER stress, enhancing its pro-apoptotic activity .

2. Therapeutic Targeting: Small-molecule inducers of DDIT3 (e.g., isochaihulactone) show promise in cancer therapy by triggering ER stress-mediated apoptosis .

3. Biomarker Potential: DDIT3 levels in serum, quantified via ELISA (CAB11346), predict disease progression in lupus and Crohn’s disease .

Challenges and Considerations

• Cross-reactivity: Some antibodies may detect splice variants (e.g., AltDDIT3) .

• Validation: Knockout controls (e.g., DDIT3-KO HeLa cells) are essential to confirm antibody specificity .